Literature DB >> 7729961

Capital sectors and workers' health and safety in the United States.

K J Greenlund1, R H Elling.   

Abstract

The dual or segmented economy perspective suggests that the U.S. production system within a capitalist world-system can be divided into distinct sectors based on elements such as levels of industrial concentration, foreign involvement, and unionization. The differing organization of these sectors is argued to influence worker health and safety (WHS) outcomes. An economic segmentation model was applied to national occupational health data to examine the relationship between structural divisions in the economy and occupational hazard exposure, injury, and illness. Workers in more global industrial sectors had only average levels of hazardous exposure but a greater likelihood of occupational injury and illness than workers in other sectors of the economy. These differences are related to the structure of work in the various sectors. The findings suggest the need for (1) greater surveillance and reporting of WHS problems through the general health care system; (2) planning of economic and productive activity that takes WHS issues into account; and (3) greater worker organization and power within and between nations to improve WHS.

Entities:  

Mesh:

Year:  1995        PMID: 7729961     DOI: 10.2190/2GP3-2D9R-DY90-HKUB

Source DB:  PubMed          Journal:  Int J Health Serv        ISSN: 0020-7314            Impact factor:   1.663


  2 in total

1.  Social class, race/ethnicity and all-cause mortality in the US: longitudinal results from the 1986-1994 National Health Interview Survey.

Authors:  Carles Muntaner; Wilbur C Hadden; Nataliya Kravets
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

2.  An empirical analysis on labor unions and occupational safety and health committees' activity, and their relation to the changes in occupational injury and illness rate.

Authors:  Kwan Hyung Yi; Hm Hak Cho; Jiyun Kim
Journal:  Saf Health Work       Date:  2011-12-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.